Literature DB >> 8688675

Inhibition of leukotriene synthesis by honokiol in rat basophilic leukemia cells.

Y Hamasaki1, E Muro, S Miyanji, S Yamamoto, I Kobayashi, R Sato, M Zaitu, M Matsuo, T Ichimaru, H Tasaki, S Miyazaki.   

Abstract

The effects of honokiol, a diphenyl compound extracted from a Chinese herbal medicine, on leukotriene (LT) synthesis were evaluated in rat basophilic leukemia (RBL) cells. The production of LTC4 and LTB4 stimulated by the Ca2+ ionophore A23187 was measured in RBL-1 cells by high-performance liquid chromatography. Honokiol inhibited the production of LTC4 and LTB4 stimulated by A23187 in RBL-1 cells. Honokiol did not inhibit either phospholipase A2 activity, measured by the release of 3H-arachidonic acid (AA), or LTC4 synthase and LTA4 hydrolase activities, measured with LTA4-free acid as substrate. The synthesis of LTC4 and LTB4 from AA in RBL-1 cell lysates in the presence of Ca2+ was inhibited by honokiol. These results indicate that honokiol blocks LT synthesis by inhibiting 5-lipoxygenase activity. Honokiol also inhibited immunoglobulin E-mediated production of these LTs in RBL-2H3 cells, which was measured by a specific radioimmunoassay (RIA). These results suggest that honokiol may exhibit antiallergic actions by inhibiting LT synthesis in immediate-type hyperreactivity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8688675     DOI: 10.1159/000237299

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  6 in total

1.  Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and consequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2-dependent signals.

Authors:  Shing Hwa Liu; Chin Chang Shen; Yu Chiao Yi; Jaw Ji Tsai; Chih Chien Wang; Ju Ting Chueh; Keh Liang Lin; Tso Ching Lee; Hung Chuan Pan; Meei Ling Sheu
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Honokiol activates reactive oxygen species-mediated cytoprotective autophagy in human prostate cancer cells.

Authors:  Eun-Ryeong Hahm; Kozue Sakao; Shivendra V Singh
Journal:  Prostate       Date:  2014-07-07       Impact factor: 4.104

Review 3.  Honokiol, a multifunctional antiangiogenic and antitumor agent.

Authors:  Levi E Fried; Jack L Arbiser
Journal:  Antioxid Redox Signal       Date:  2009-05       Impact factor: 8.401

4.  Therapeutic effect of 28-homobrassinolide on leukotriene synthesis in leukemia cells.

Authors:  Chuan He; Zhigang Liu; Jingcao Huang; Ting Liu
Journal:  Cytotechnology       Date:  2017-11-03       Impact factor: 2.058

5.  Honokiol Protected against Heatstroke-Induced Oxidative Stress and Inflammation in Diabetic Rats.

Authors:  Chuan-Chih Hsu; Li-Fan Chen; Mao-Tsun Lin; Yu-Feng Tian
Journal:  Int J Endocrinol       Date:  2014-02-17       Impact factor: 3.257

6.  Synthesis of tetrahydrohonokiol derivates and their evaluation for cytotoxic activity against CCRF-CEM leukemia, U251 glioblastoma and HCT-116 colon cancer cells.

Authors:  Marketa Bernaskova; Nadine Kretschmer; Wolfgang Schuehly; Antje Huefner; Robert Weis; Rudolf Bauer
Journal:  Molecules       Date:  2014-01-20       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.